Is It Time To Reassess Danaher (DHR) After Recent Share Price Recovery?
- If you are wondering whether Danaher stock at around US$183.63 offers fair value or a potential discount, a useful starting point is understanding how its current price lines up against different valuation checks.
- The stock has gained 3.1% over the past week and 10.3% over the past month, yet year to date it is down 20.3% and over the last year it is down 9.7%. This may leave you questioning whether recent moves reflect changing prospects or simply shifting risk appetite.
- Recent coverage has focused on how investors are reassessing large healthcare and life sciences companies in light of shifting capital allocation priorities and ongoing M&A interest across the sector. This context helps frame why a stock like Danaher can see short…
Source link
